Eli Lilly’s Zepbound in shortage months after approval
The weight loss medication Zepbound has gone into shortage just months after it was approved by the Food and Drug Administration (FDA), with its manufacturer Eli Lilly blaming the situation on high demand. As of this week, most tirzepatide injections (sold commercially as Mounjaro and Zepbound) have limited availability, according to the FDA’s shortage database. … Read more
